Aukje K Mantel-Teeuwisse (Aukje Mantel-Teeuwisse, A K Mantel-Teeuwisse)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 43

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Childhood Cancer

Top Venues

Journal of pharmaceutical policy and practice

BMJ (Clinical research ed.)

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
High cost oncology drugs without proof of added benefit are burdening health systems. BMJ (Clinical research ed.) 384 (2024)
Iris R Joosse, Hendrika A van den Ham, Aukje K Mantel-Teeuwisse, Velisha Ann Perumal-Pillay, Fatima Suleman
Access to childhood cancer medicines in South Africa: a health systems analysis of barriers and enablers. Journal of pharmaceutical policy and practice 17 (1) (2024)
Sabine Vogler, Nina Zimmermann, Manuel Alexander Haasis, Verena Knoll, Jaime Espin, Aukje K Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J Wirtz, Zaheer Ud-Din Babaar
Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines. Journal of pharmaceutical policy and practice 17 (Suppl 1) (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
High cost oncology drugs without proof of added benefit are burdening health systems. BMJ (Clinical research ed.) 384 (2024)
Iris R Joosse, Aukje K Mantel-Teeuwisse, Fatima Suleman, Hendrika A van den Ham
Monitoring Access to Child Medicines: Introducing a Standardized Set of Age-Appropriate Medicines. Children (Basel, Switzerland) 11 (3) (2024)
Li Jiu, Michiel Hartog, Junfeng Wang, Rick A Vreman, Olaf H Klungel, Aukje K Mantel-Teeuwisse, Wim G Goettsch
Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis. BMJ open 14 (2) (2024)
Iris R Joosse, Aukje K Mantel-Teeuwisse, Fatima Suleman, Hendrika A van den Ham
Monitoring Access to Child Medicines: Introducing a Standardized Set of Age-Appropriate Medicines. Children (Basel, Switzerland) 11 (3) (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. BMJ (Clinical research ed.) 384 (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. BMJ (Clinical research ed.) 384 (2024)
Doerine J Postma, Magali L A Heijkoop, P A G M Peter De Smet, Kim Notenboom, Hubertus G Leufkens, Aukje K Mantel-Teeuwisse
Identifying Medicine Shortages With the Twitter Social Network: Retrospective Observational Study. Journal of medical Internet research 26 (2024)
Doerine J Postma, Magali L A Heijkoop, P A G M Peter De Smet, Kim Notenboom, Hubertus G Leufkens, Aukje K Mantel-Teeuwisse
Identifying Medicine Shortages With the Twitter Social Network: Retrospective Observational Study. Journal of medical Internet research 26 (2024)
Li Jiu, Michiel Hartog, Junfeng Wang, Rick A Vreman, Olaf H Klungel, Aukje K Mantel-Teeuwisse, Wim G Goettsch
Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis. BMJ open 14 (2) (2024)
Iris R Joosse, Hendrika A van den Ham, Aukje K Mantel-Teeuwisse, Velisha Ann Perumal-Pillay, Fatima Suleman
Access to childhood cancer medicines in South Africa: a health systems analysis of barriers and enablers. Journal of pharmaceutical policy and practice 17 (1) (2024)
Iris R Joosse, Hendrika A van den Ham, Aukje K Mantel-Teeuwisse, Fatima Suleman
The caregiver's experience of childhood cancer treatment in South Africa. Journal of pharmaceutical policy and practice 17 (1) (2024)
Sabine Vogler, Nina Zimmermann, Manuel Alexander Haasis, Verena Knoll, Jaime Espin, Aukje K Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J Wirtz, Zaheer Ud-Din Babaar
Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines. Journal of pharmaceutical policy and practice 17 (Suppl 1) (2024)
Tom G Jacobs, Dorothy Okemo, Anthony Ssebagereka, Kenneth Mwehonge, Emily M Njuguna, David Marinus Burger, Angela Colbers, Fatima Suleman, Aukje K Mantel-Teeuwisse, Gaby Isabelle Ooms
Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda. HIV medicine 25 (7) (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. BMJ (Clinical research ed.) 384 (2024)
Iris R Joosse, Hendrika A van den Ham, Aukje K Mantel-Teeuwisse, Fatima Suleman
The caregiver's experience of childhood cancer treatment in South Africa. Journal of pharmaceutical policy and practice 17 (1) (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
High cost oncology drugs without proof of added benefit are burdening health systems. BMJ (Clinical research ed.) 384 (2024)
Li Jiu, Michiel Hartog, Junfeng Wang, Rick A Vreman, Olaf H Klungel, Aukje K Mantel-Teeuwisse, Wim G Goettsch
Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis. BMJ open 14 (2) (2024)
Tom G Jacobs, Dorothy Okemo, Anthony Ssebagereka, Kenneth Mwehonge, Emily M Njuguna, David Marinus Burger, Angela Colbers, Fatima Suleman, Aukje K Mantel-Teeuwisse, Gaby Isabelle Ooms
Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda. HIV medicine (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. BMJ (Clinical research ed.) 384 (2024)
Marloes Dankers, Peeter Verlegh, Karla Weber, Marjorie Nelissen-Vrancken, Liset van Dijk, Aukje K Mantel-Teeuwisse
Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements. PloS one 18 (8) (2023)
Iris R Joosse, Aukje K Mantel-Teeuwisse, Fatima Suleman, Hendrika A van den Ham
Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study. BMJ open 13 (4) (2023)
Milou Amber Hogervorst, Mathias Møllebæk, Rick A Vreman, Ting-An Lu, Junfeng Wang, Marie Louise De Bruin, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse, Wim Goettsch
Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts. BMJ open 13 (8) (2023)
E Petro, V Perumal-Pillay, Aukje K Mantel-Teeuwisse, Hendrika A van den Ham, Fatima Suleman
Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children. Journal of pharmaceutical policy and practice 17 (1) (2023)
E Petro, V Perumal-Pillay, Aukje K Mantel-Teeuwisse, Hendrika A van den Ham, Fatima Suleman
Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children. Journal of pharmaceutical policy and practice 17 (1) (2023)
Marcelien H E Callenbach, Rick A Vreman, Aukje K Mantel-Teeuwisse, Wim G Goettsch
When Reality Does Not Meet Expectations-Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs. International journal of environmental research and public health 20 (1) (2022)
Marcelien H E Callenbach, Rick A Vreman, Aukje K Mantel-Teeuwisse, Wim G Goettsch
When Reality Does Not Meet Expectations-Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs. International journal of environmental research and public health 20 (1) (2022)
Marloes Dankers, Karin Hek, Marjorie Nelissen-Vrancken, Sebastiaan T Houweling, Aukje K Mantel-Teeuwisse, Liset van Dijk
Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study. The British journal of general practice : the journal of the Royal College of General Practitioners 72 (719) (2022)
Joris J Komen, Jesper Hallas, Aukje K Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Nina Sahlertz Kristiansen, Morten Olesen, Marion Bennie, Tanja Mueller, Raymond Carragher, Øystein Karlstad, Lars Jøran Kjerpeseth, Olaf H Klungel
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study. European heart journal 43 (37) (2022)
Marcelien H E Callenbach, Rick A Vreman, Aukje K Mantel-Teeuwisse, Wim G Goettsch
When Reality Does Not Meet Expectations-Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs. International journal of environmental research and public health 20 (1) (2022)
Marcelien H E Callenbach, Rick A Vreman, Aukje K Mantel-Teeuwisse, Wim G Goettsch
When Reality Does Not Meet Expectations-Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs. International journal of environmental research and public health 20 (1) (2022)
Denis Kibira, Gaby Isabelle Ooms, Hendrika A van den Ham, Juliet Sanyu Namugambe, Tim Reed, Hubert Gm Leufkens, Aukje K Mantel-Teeuwisse
Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability. BMJ open 11 (1) (2021)
Gaby Isabelle Ooms, Janneke van Oirschot, Dorothy Okemo, Benjamin Waldmann, Eugene Erulu, Aukje K Mantel-Teeuwisse, Hendrika A van den Ham, Tim Reed
Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya. PLoS neglected tropical diseases 15 (8) (2021)
Lourens T Bloem, Mariana Karomi, Jarno Hoekman, Menno E van der Elst, Hubert G M Leufkens, Olaf H Klungel, Aukje K Mantel-Teeuwisse
Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle - a focus on benefits and risks. Expert opinion on drug safety 20 (11) (2021)
Rick A Vreman, Thomas F Broekhoff, Hubert Gm Leufkens, Aukje K Mantel-Teeuwisse, Wim G Goettsch
Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis. International journal of environmental research and public health 17 (22) (2020)
Rick A Vreman, Huseyin Naci, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Sebastian G Schneeweiss, Hubertus G Leufkens, Aaron S Kesselheim
Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe. Clinical pharmacology and therapeutics 108 (2) (2020)
Ashwin R Moerlie, Renate C Van Uden, Aukje K Mantel-Teeuwisse, Patricia Maria Lucia Adriana van den Bemt, Matthijs L Becker
Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study. Pharmacy practice 18 (2) (2020)
Rick A Vreman, Lourens T Bloem, Stijn van Oirschot, Jarno Hoekman, Menno E van der Elst, Hubert Gm Leufkens, Olaf H Klungel, Wim G Goettsch, Aukje K Mantel-Teeuwisse
The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs. International journal of health policy and management (2020)
Joris J Komen, Paul Hjemdahl, Aukje K Mantel-Teeuwisse, Olaf H Klungel, Björn Wettermark, Tomas Forslund
Concomitant Anticoagulant and Antidepressant Therapy in Atrial Fibrillation Patients and Risk of Stroke and Bleeding. Clinical pharmacology and therapeutics 107 (1) (2019)
Marjolein J M Vranken, Marie-Hélène D B Schutjens, Aukje K Mantel-Teeuwisse
The double opioid crisis: A call for balance. Pharmacoepidemiology and drug safety 28 (1) (2019)
Y T Bazargani, M Ugurlu, A de Boer, H G M Leufkens, Aukje K Mantel-Teeuwisse
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries. BMC cardiovascular disorders 18 (1) (2018)